Sine Pharmaceutical (00858.HK) issued a profit warning, expecting a midterm loss of approximately 450-480 million Hong Kong dollars, a year-on-year reversal from profit to loss.

Wisdom Financial News APP reported that Jingyou Pharmaceuticals (00858.HK) announced that the group is expected to incur a loss of approximately 450 million to 480 million Hong Kong dollars for the six months ending September 30, 2025, compared to a profit for the same period ending September 30, 2024. The expected change from profit to loss in this period is mainly due to unrealized losses on fair value changes of the group's convertible bonds investment, while in the corresponding period in 2024, the same project recorded fair value gains. The unrealized losses are of a non-cash nature. During this period, the performance of the group's operating segments remained stable.